Supported through funding by
USA-CBU-81650
Please Click the Issue to Download
Introduction
In this supplement, expert faculty offer detailed perspectives based on their
experience to summarize, examine, and analyze the emerging results from
studies of anticancer biosimilars and provide recommendations to improve the
adoption of and access to biosimilar products.